查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1975224

全球病患登記軟體市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Patient Registry Software Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 236 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

病患登記軟體市場預計將從 2025 年的 14.9 億美元成長到 2034 年的 35.6 億美元，2026 年至 2034 年的複合年成長率為 10.17%。

隨著醫療機構和研究機構日益重視數據驅動的決策，全球患者登記軟體市場正在快速成長。患者登記平台收集和管理與特定疾病、治療或人群相關的數據，以便更好地監測治療效果和長期趨勢。人們對個人化醫療和人群健康管理的日益關注，正在推動對這些解決方案的需求。

關鍵成長要素包括慢性病和罕見病患疾病的上升、臨床研究活動的擴展以及監管核准中對真實世界數據的需求。各國政府和醫療機構正在投資數位化工具，以改善流行病學追蹤和衛生計畫評估。基於雲端的註冊系統進一步提高了可存取性和擴充性。

展望未來，由於先進分析技術、人工智慧以及與電子健康記錄（EHR）系統的互通性不斷提升，市場預計將顯著擴張。製藥公司與醫療服務提供者之間合作的加強也將促進市場應用。隨著精準醫療的不斷發展，病患登記軟體將在改進臨床研究和患者照護策略方面繼續發揮核心作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球病患登記軟體市場：按類型分類

  • 市場分析、洞察與預測
  • 疾病登記處（心血管疾病登記處、癌症登記處、罕見疾病登記處、氣喘登記處、慢性腎臟病登記處及其他登記處）
  • 醫療保健服務登記處
  • 產品註冊

第5章 全球病患登記軟體市場：依軟體類型分類

  • 市場分析、洞察與預測
  • 獨立版
  • 融合的

第6章：全球病患登記軟體市場：依定價模式

  • 市場分析、洞察與預測
  • 訂閱
  • 所有權

第7章 全球病患登記軟體市場：依部署模式分類

  • 市場分析、洞察與預測
  • 現場
  • 基於雲端的

第8章 全球病患登記軟體市場：依資料庫

  • 市場分析、洞察與預測
  • 商業的
  • 公共

第9章：全球病患登記軟體市場：功能

  • 市場分析、洞察與預測
  • PHM
  • 交換醫療資訊
  • 患者照護管理
  • 照護端
  • 醫學研究和臨床試驗
  • 產品性能評估

第10章 全球病患登記軟體市場：依最終用途分類

  • 市場分析、洞察與預測
  • 政府機構和第三方管理機構
  • 醫院和診所
  • 私人保險公司
  • 製藥、生技和醫療設備公司
  • 研究中心

第11章 全球病患登記軟體市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 亞太其他地區
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第12章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第13章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Global Vision Technology
    • IQVIA Inc
    • Dacima Software Inc
    • McKesson Corporation
    • OpenText Corporation
    • ImageTrend Inc
    • Evado Clinical
    • IFA Systems AG
    • VersaForm Systems Corporation
    • IBM Corporation
    • Optum Inc
簡介目錄
Product Code: VMR112112144

The Patient Registry Software Market size is expected to reach USD 3.56 Billion in 2034 from USD 1.49 Billion (2025) growing at a CAGR of 10.17% during 2026-2034.

The Global Patient Registry Software Market is growing rapidly as healthcare providers and research institutions emphasize data-driven decision-making. Patient registry platforms collect and manage data related to specific diseases, treatments, or populations, enabling better monitoring of outcomes and long-term trends. Increasing focus on personalized medicine and population health management is fueling demand for such solutions.

Key growth drivers include the rising prevalence of chronic and rare diseases, expansion of clinical research activities, and the need for real-world evidence in regulatory approvals. Governments and healthcare organizations are investing in digital tools that improve epidemiological tracking and health program evaluation. Cloud-based registry systems are further enhancing accessibility and scalability.

Looking forward, the market is poised for substantial expansion with the integration of advanced analytics, artificial intelligence, and interoperability with EHR systems. Growing collaborations between pharmaceutical companies and healthcare providers will also boost adoption. As precision medicine continues to evolve, patient registry software will remain central to clinical research and improved patient care strategies.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • Disease Registry (Cardiovascular Registries, Cancer Registries, Rare Disease Registries, Asthma Registries, Chronic Kidney Disease Registries, Other Registries)
  • Health Service Registry
  • Product Registry

By Software

  • Standalone
  • Integrated

By Pricing Model

  • Subscription
  • Ownership

By Deployment Model

  • On Premise
  • Cloud Based

By Database

  • Commercial
  • Public

By Functionality

  • PHM
  • Health Information Exchange
  • Patient Care Management
  • Point-of-Care
  • Medical Research & Clinical Studies
  • Product Outcome Evaluation

By End Use

  • Government Organizations & Third-Party Administrators
  • Hospitals and Medical Practices
  • Private Payers
  • Pharmaceutical, Biotechnology, and Medical Device Companies
  • Research Centers

COMPANIES PROFILED

  • Global Vision Technology, IQVIA Inc, Dacima Software Inc, McKesson Corporation, OpenText Corporation, ImageTrend Inc, Evado Clinical, IFA Systems AG, VersaForm Systems Corporation, IBM Corporation, Optum Inc
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PATIENT REGISTRY SOFTWARE MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Disease Registry (Cardiovascular Registries, Cancer Registries, Rare Disease Registries, Asthma Registries, Chronic Kidney Disease Registries, Other Registries) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Health Service Registry Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Product Registry Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PATIENT REGISTRY SOFTWARE MARKET: BY SOFTWARE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Software
  • 5.2. Standalone Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Integrated Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PATIENT REGISTRY SOFTWARE MARKET: BY PRICING MODEL 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Pricing Model
  • 6.2. Subscription Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ownership Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PATIENT REGISTRY SOFTWARE MARKET: BY DEPLOYMENT MODEL 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Deployment Model
  • 7.2. On Premise Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Cloud Based Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PATIENT REGISTRY SOFTWARE MARKET: BY DATABASE 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast Database
  • 8.2. Commercial Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Public Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL PATIENT REGISTRY SOFTWARE MARKET: BY FUNCTIONALITY 2022-2034 (USD MN)

  • 9.1. Market Analysis, Insights and Forecast Functionality
  • 9.2. PHM Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 9.3. Health Information Exchange Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 9.4. Patient Care Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 9.5. Point-of-Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 9.6. Medical Research & Clinical Studies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 9.7. Product Outcome Evaluation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL PATIENT REGISTRY SOFTWARE MARKET: BY END USE 2022-2034 (USD MN)

  • 10.1. Market Analysis, Insights and Forecast End Use
  • 10.2. Government Organizations & Third-Party Administrators Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 10.3. Hospitals and Medical Practices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 10.4. Private Payers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 10.5. Pharmaceutical, Biotechnology, and Medical Device Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 10.6. Research Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 11. GLOBAL PATIENT REGISTRY SOFTWARE MARKET: BY REGION 2022-2034(USD MN)

  • 11.1. Regional Outlook
  • 11.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 11.2.1 By Type
    • 11.2.2 By Software
    • 11.2.3 By Pricing Model
    • 11.2.4 By Deployment Model
    • 11.2.5 By Database
    • 11.2.6 By Functionality
    • 11.2.7 By End Use
    • 11.2.8 United States
    • 11.2.9 Canada
    • 11.2.10 Mexico
  • 11.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 11.3.1 By Type
    • 11.3.2 By Software
    • 11.3.3 By Pricing Model
    • 11.3.4 By Deployment Model
    • 11.3.5 By Database
    • 11.3.6 By Functionality
    • 11.3.7 By End Use
    • 11.3.8 United Kingdom
    • 11.3.9 France
    • 11.3.10 Germany
    • 11.3.11 Italy
    • 11.3.12 Russia
    • 11.3.13 Rest Of Europe
  • 11.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 11.4.1 By Type
    • 11.4.2 By Software
    • 11.4.3 By Pricing Model
    • 11.4.4 By Deployment Model
    • 11.4.5 By Database
    • 11.4.6 By Functionality
    • 11.4.7 By End Use
    • 11.4.8 India
    • 11.4.9 Japan
    • 11.4.10 South Korea
    • 11.4.11 Australia
    • 11.4.12 South East Asia
    • 11.4.13 Rest Of Asia Pacific
  • 11.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 11.5.1 By Type
    • 11.5.2 By Software
    • 11.5.3 By Pricing Model
    • 11.5.4 By Deployment Model
    • 11.5.5 By Database
    • 11.5.6 By Functionality
    • 11.5.7 By End Use
    • 11.5.8 Brazil
    • 11.5.9 Argentina
    • 11.5.10 Peru
    • 11.5.11 Chile
    • 11.5.12 South East Asia
    • 11.5.13 Rest of Latin America
  • 11.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 11.6.1 By Type
    • 11.6.2 By Software
    • 11.6.3 By Pricing Model
    • 11.6.4 By Deployment Model
    • 11.6.5 By Database
    • 11.6.6 By Functionality
    • 11.6.7 By End Use
    • 11.6.8 Saudi Arabia
    • 11.6.9 UAE
    • 11.6.10 Israel
    • 11.6.11 South Africa
    • 11.6.12 Rest of the Middle East And Africa

Chapter 12. COMPETITIVE LANDSCAPE

  • 12.1. Recent Developments
  • 12.2. Company Categorization
  • 12.3. Supply Chain & Channel Partners (based on availability)
  • 12.4. Market Share & Positioning Analysis (based on availability)
  • 12.5. Vendor Landscape (based on availability)
  • 12.6. Strategy Mapping

Chapter 13. COMPANY PROFILES OF GLOBAL PATIENT REGISTRY SOFTWARE INDUSTRY

  • 13.1. Top Companies Market Share Analysis
  • 13.2. Company Profiles
    • 13.2.1 Global Vision Technology
    • 13.2.2 IQVIA Inc
    • 13.2.3 Dacima Software Inc
    • 13.2.4 McKesson Corporation
    • 13.2.5 OpenText Corporation
    • 13.2.6 ImageTrend Inc
    • 13.2.7 Evado Clinical
    • 13.2.8 IFA Systems AG
    • 13.2.9 VersaForm Systems Corporation
    • 13.2.10 IBM Corporation
    • 13.2.11 Optum Inc